Anika Therapeutics, Inc. (ANIK)
Data as of , from SEC Form 4 filings.
Net insider buying (90d)Watch ANIK
See up to 3 months of ANIK. The 7-day demo opens the 1M and 3M ranges and puts ANIK on your watchlist.
Start 7-day demoLatest ANIK insider trades
Gary P. Fischetti - DirectorOpen-market purchase$21K- Gary P. Fischetti - DirectorOpen-market purchase$20K
About Anika Therapeutics, Inc. (ANIK)
Anika Therapeutics, Inc. files with the SEC under CIK 0000898437 and is classified as surgical and medical instruments and apparatus. We track it alongside the rest of the Health Care sector.
ANIK Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market purchase | 2 | 2,000 | $41K |
ANIK insider transactions (Form 4)
5722 Form 4 filings on record, the earliest from Oct 4, 2024, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Gary P. Fischetti - Director | Open-market purchase | Common Stock | 1,000 | $20.75 | $21K | |
| Gary P. Fischetti - Director | Open-market purchase | Common Stock | 1,000 | $20.32 | $20K | |
| Gary P. Fischetti | Grant or award | Common Stock | 10,402 footnote F1 | $0.00 | - | |
| ||||||
| John B. Henneman III | Grant or award | Common Stock | 10,402 footnote F1 | $0.00 | - | |
| ||||||
| Stephen Richard | Grant or award | Common Stock | 10,402 footnote F1 | $0.00 | - | |
| ||||||
 Joseph H. Capper | Grant or award | Common Stock | 10,402 footnote F1 | $0.00 | - | |
| ||||||
| Sheryl L. Conley | Grant or award | Common Stock | 10,402 footnote F1 | $0.00 | - | |
| ||||||
 Stephen D. Griffin - Officer | Option exercise | Common Stock | 12,840 | - footnote F1 | - | |
| Stephen D. Griffin - Officer | Tax withholding / forfeiture | Common Stock | 3,769 footnote F3 | $14.41 | $54K | |
| Stephen D. Griffin - Officer | Option exercise | Restricted Stock Unit | 12,840 | $0.00 | - | |
| ||||||
| John B. Henneman III | Open-market purchase | Common Stock | 5,000 | $14.66 footnote F1 | $73K | |
| ||||||
| Ian McLeod - Officer | Grant or award | Restricted Stock Unit | 13,097 | $0.00 | - | |
| Ian McLeod - Officer | Grant or award | Restricted Stock Unit | 11,194 | $0.00 | - | |
| Ian McLeod - Officer | Grant or award | Premium Priced Stock Appreciation Rights | 17,663 | $0.00 | - | |
| David Colleran - Officer | Option exercise | Common Stock | 9,388 | - footnote F1 | - | |
| David Colleran - Officer | Grant or award | Common Stock | 4,694 footnote F2 | $0.00 | - | |
| David Colleran - Officer | Tax withholding / forfeiture | Common Stock | 4,168 footnote F3 | $14.20 | $59K | |
| David Colleran - Officer | Option exercise | Common Stock | 6,449 | - footnote F1 | - | |
| David Colleran - Officer | Tax withholding / forfeiture | Common Stock | 1,893 footnote F4 | $14.20 | $27K | |
| David Colleran - Officer | Option exercise | Restricted Stock Unit | 9,388 | $0.00 | - | |
| David Colleran - Officer | Option exercise | Restricted Stock Unit | 6,449 | $0.00 | - | |
| ||||||
| Stephen D. Griffin - Officer | Option exercise | Common Stock | 12,824 | - footnote F1 | - | |
| Stephen D. Griffin - Officer | Grant or award | Common Stock | 6,412 footnote F2 | $0.00 | - | |
| Stephen D. Griffin - Officer | Tax withholding / forfeiture | Common Stock | 5,944 footnote F3 | $14.20 | $84K | |
| Stephen D. Griffin - Officer | Option exercise | Restricted Stock Unit | 12,824 | $0.00 | - | |
| ||||||
| Cheryl R. Blanchard | Option exercise | Common Stock | 24,519 | - footnote F1 | - | |
| Cheryl R. Blanchard | Grant or award | Common Stock | 24,520 footnote F2 | $0.00 | - | |
| Cheryl R. Blanchard | Tax withholding / forfeiture | Common Stock | 14,728 footnote F3 | $14.20 | $209K | |
| Cheryl R. Blanchard | Option exercise | Common Stock | 25,131 | - footnote F1 | - | |
| Cheryl R. Blanchard | Tax withholding / forfeiture | Common Stock | 12,104 footnote F4 | $14.20 | $172K | |
| Cheryl R. Blanchard | Option exercise | Restricted Stock Unit | 24,519 | $0.00 | - | |
| Cheryl R. Blanchard | Option exercise | Restricted Stock Unit | 25,131 | $0.00 | - | |
| ||||||
| Ian McLeod - Officer | Option exercise | Common Stock | 3,774 | - footnote F1 | - | |
| Ian McLeod - Officer | Grant or award | Common Stock | 1,161 footnote F2 | $0.00 | - | |
| Ian McLeod - Officer | Tax withholding / forfeiture | Common Stock | 1,449 footnote F3 | $14.20 | $21K | |
| Ian McLeod - Officer | Option exercise | Common Stock | 2,658 | - footnote F1 | - | |
| Ian McLeod - Officer | Tax withholding / forfeiture | Common Stock | 781 footnote F4 | $14.20 | $11K | |
| Ian McLeod - Officer | Option exercise | Restricted Stock Unit | 3,774 | $0.00 | - | |
| Ian McLeod - Officer | Option exercise | Restricted Stock Unit | 2,658 | $0.00 | - | |
| ||||||
| David Colleran - Officer | Option exercise | Restricted Stock Unit | 5,465 | $0.00 | - | |
| David Colleran - Officer | Option exercise | Common Stock | 5,465 | - footnote F1 | - | |
| David Colleran - Officer | Tax withholding / forfeiture | Common Stock | 1,919 footnote F3 | $14.96 | $29K | |
| ||||||
| Cheryl R. Blanchard | Option exercise | Common Stock | 20,001 | - footnote F1 | - | |
| Cheryl R. Blanchard | Tax withholding / forfeiture | Common Stock | 5,871 footnote F2 | $14.96 | $88K | |
| Cheryl R. Blanchard | Option exercise | Restricted Stock Unit | 20,001 | $0.00 | - | |
| ||||||
| Ian McLeod - Officer | Option exercise | Common Stock | 2,197 | - footnote F1 | - | |
| Ian McLeod - Officer | Tax withholding / forfeiture | Common Stock | 639 footnote F3 | $14.96 | $10K | |
| Ian McLeod - Officer | Option exercise | Restricted Stock Unit | 2,197 | $0.00 | - | |
| ||||||
| Stephen D. Griffin - Officer | Grant or award | Stock Appreciation Rights | 310,207 | $0.00 | - | |
| Stephen D. Griffin - Officer | Grant or award | Restricted Stock Unit | 130,402 | $0.00 | - | |
| Sheryl L. Conley - Director | Grant or award | Common Stock | 14,164 | $0.00 | - | |
| Susan L. N. Vogt - Director | Grant or award | Common Stock | 14,164 | $0.00 | - | |
| William R. Jellison - Director | Grant or award | Common Stock | 14,164 | $0.00 | - | |
| John B. Henneman III - Director | Grant or award | Common Stock | 14,164 | $0.00 | - | |
| Anne Nunes - Officer | Option exercise | Common Stock | 2,491 | $0.00 | - | |
| Anne Nunes - Officer | Tax withholding / forfeiture | Common Stock | 732 | $24.27 | $18K | |
| Anne Nunes - Officer | Option exercise | Restricted Stock Unit | 2,491 | $0.00 | - | |
Item 2.02, 9.01
Item 1.01, 2.03, 9.01
Item 5.02, 5.07, 9.01
Item 2.02, 5.02, 9.01
Recent ANIK Form 144 notices of proposed sale
1An insider files Form 144 before selling restricted or control stock. It announces a planned sale. If the sale goes ahead, it shows up later on a Form 4.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| Jellison William R | Former Director | 16,864 | $355K | View on EDGAR |
ANIK insider trading FAQ
What is the latest insider trade for ANIK?
Anika Therapeutics, Inc. (ANIK) had 1 insider filing in the last 90 days, with the most recent on 2026-08-05. The full record for ANIK runs to 22 Form 4 filings, the earliest from 2024-10-04. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying ANIK stock?
2 insider purchases of ANIK were filed in the last 90 days, totaling $41K.
How many insiders are selling ANIK stock?
No insider sales of ANIK were filed in the last 90 days.
Where can I see ANIK SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects ANIK Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Gary P. Fischetti view on EDGAR
- - Gary P. Fischetti view on EDGAR
- - John B. Henneman III view on EDGAR
- - Stephen Richard view on EDGAR
- - Joseph H. Capper view on EDGAR
- - Sheryl L. Conley view on EDGAR
- - Stephen D. Griffin view on EDGAR
- - John B. Henneman III view on EDGAR
- - Ian McLeod view on EDGAR
Related companies with recent insider activity
Learn more
- How to read insider buying signals
- What an open-market purchase by an insider can and cannot tell you.
- Form 144 vs Form 4
- A Form 144 announces a planned sale; the Form 4 reports it after it happens.
- Insider activity in Health Care
- Where ANIK's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow ANIK with a 7-day demo
- ANIK on your watchlist
- Every ANIK Form 4 filing on record
- Up to 3 months of ANIK price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
Start 7-day demoCard required. Your card is never charged for the demo.
